NewEdge Wealth’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$429K Buy
4,432
+651
+17% +$66.8K 0.01% 862
2025
Q4
$401K Buy
3,781
+393
+12% +$45.6K ﹤0.01% 918
2025
Q3
$391K Sell
3,388
-77
-2% -$9.17K 0.01% 812
2025
Q2
$404K Buy
3,465
+1,167
+51% +$133K 0.01% 759
2025
Q1
$233K Buy
+2,298
New +$224K ﹤0.01% 847
2022
Q1
Sell
-9,930
Closed -$516K 420
2021
Q4
$516K Buy
+9,930
New +$512K 0.02% 289

Other funds holding EHC

NewEdge Wealth's EHC Position: Q1 2026 in Review

NewEdge Wealth increased its Encompass Health (EHC) stake by 17% in Q1 2026, buying an estimated $66.8K and bringing the position to 4,432 shares worth $429K. The position accounts for 0.01% of the portfolio, ranked #862.

NewEdge Wealth first reported a position in EHC in Q4 2021 and has held it in 6 quarters since. The position peaked at $516K in Q4 2021. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • NewEdge Wealth held 4,432 shares of Encompass Health worth $429K as of Q1 2026.
  • NewEdge Wealth bought 651 Encompass Health shares in Q1 2026, an estimated $66.8K.
  • Encompass Health made up 0.01% of NewEdge Wealth's portfolio in Q1 2026, its #862 holding.
  • NewEdge Wealth first reported a position in Encompass Health in Q4 2021 and has held it in 6 quarters since.
  • NewEdge Wealth's Encompass Health position peaked at $516K in Q4 2021.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on NewEdge Wealth's 13F filing for Q1 2026, filed 13 May 2026.